[{"AccountsPayableCurrent_0_Q3_USD":19693000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":-3000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-1000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":27000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":114000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":28000.0,"OtherAssetsNoncurrent_0_Q3_USD":5191000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.125,"OperatingLeaseRightOfUseAsset_0_Q3_USD":5191000.0,"OperatingLeasePayments_3_Q3_USD":1125000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":5035000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1452000.0,"OperatingLeaseExpense_3_Q3_USD":1306000.0,"OperatingIncomeLoss_3_Q3_USD":-125543000.0,"OperatingIncomeLoss_1_Q3_USD":-44584000.0,"NotesPayableCurrent_0_Q3_USD":30000000.0,"NetIncomeLoss_1_Q3_USD":-58801000.0,"NetIncomeLoss_3_Q3_USD":-166283000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-109698000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":26924000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":12250000.0,"LongTermDebtNoncurrent_0_Q3_USD":132050000.0,"LiabilitiesCurrent_0_Q3_USD":133608000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":265763000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":5916000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":485000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1418000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":875000.0,"PaidInKindInterest_3_Q3_USD":12871000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":0.0,"PaymentsToAcquireProductiveAssets_3_Q3_USD":1277000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":3535000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":1241000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q3_shares":942000.0,"StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3_Q3_shares":316000.0,"StockholdersEquity_0_Q3_USD":-147044000.0,"ShareBasedCompensation_3_Q3_USD":26140000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":83431000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":34992000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":110012000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":40994000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1189725000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q3_USD":4296000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":145279000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":724000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":49971000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_3_Q3_USD":1000.0,"ReceivablesNetCurrent_0_Q3_USD":3286000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":7829000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":12250000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":28201000.0,"ProceedsFromIssuanceOfWarrants_3_Q3_USD":0.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":0.0,"ProceedsFromCollaborators_3_Q3_USD":6918000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":8975000.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":5000000.0,"RepaymentsOfLinesOfCredit_3_Q3_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":179106.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1574000.0,"Investments_0_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-166172000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-58774000.0,"CommonStockValue_0_Q3_USD":1798000.0,"CommonStockSharesOutstanding_0_Q3_shares":179791000.0,"CommonStockSharesIssued_0_Q3_shares":179791000.0,"CommonStockSharesAuthorized_0_Q3_shares":450000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-70455000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":203893000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":199597000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":0.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":28239000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":28211000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":3000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":6000.0,"AssetsCurrent_0_Q3_USD":252743000.0,"Assets_0_Q3_USD":265763000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":26131000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":28472000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":26140000.0,"AdvertisingExpense_3_Q3_USD":4696000.0,"AdvertisingExpense_1_Q3_USD":1492000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":13029000.0,"AdditionalPaidInCapital_0_Q3_USD":1040769000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":114000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":56308000.0,"AccountsReceivableNetCurrent_0_Q3_USD":26212000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":591000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":6811000.0,"CostsAndExpenses_1_Q3_USD":85578000.0,"CostsAndExpenses_3_Q3_USD":235555000.0,"InventoryWorkInProcess_0_Q3_USD":6619000.0,"InventoryValuationReserves_0_Q3_USD":423000.0,"InventoryRawMaterials_0_Q3_USD":6830000.0,"InventoryNet_0_Q3_USD":13663000.0,"InventoryGross_0_Q3_USD":14086000.0,"InventoryFinishedGoods_0_Q3_USD":637000.0,"InterestPayableCurrent_0_Q3_USD":25553000.0,"InterestExpenseDebt_3_Q3_USD":40514000.0,"InterestExpenseDebt_1_Q3_USD":14115000.0,"InterestExpense_3_Q3_USD":40514000.0,"InterestExpense_1_Q3_USD":14115000.0,"IncreaseDecreaseInReceivables_3_Q3_USD":17579000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":3460000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":12403000.0,"IncreaseDecreaseInInventories_3_Q3_USD":6630000.0,"IncreaseDecreaseInDerivativeAssets_3_Q3_USD":0.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":457000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":16692000.0,"GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_3_Q3_USD":-274000.0,"GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_1_Q3_USD":-111000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":5035000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":1452000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q3_USD":60420000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":69000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-930.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-330.0,"DepreciationDepletionAndAmortization_3_Q3_USD":606000.0,"DeferredRevenueCurrent_0_Q3_USD":602000.0,"IncreaseDecreaseInInterestPayableNet_3_Q3_USD":3884000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":178199.0,"Ticker":"BCRX","CIK":"882796","name":"BIOCRYST PHARMACEUTICALS INC","OfficialName":"BioCryst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1887243586.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]